FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

491811000001108: Motipress tablets (Sanofi-Synthelabo Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17398701000001115 Motipress tablets (Sanofi-Synthelabo Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
17398801000001112 Motipress tablets (Sanofi-Synthelabo Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Motipress tablets (Sanofi-Synthelabo Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Motipress tablets (Sanofi-Synthelabo Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Motipress tablets (Sanofi-Synthelabo Ltd) Is a Product containing precisely fluphenazine hydrochloride 1.5 milligram and nortriptyline 30 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Motipress tablets (Sanofi-Synthelabo Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Motipress tablets (Sanofi-Synthelabo Ltd) Has excipient Beeswax false Inferred relationship Existential restriction modifier
Motipress tablets (Sanofi-Synthelabo Ltd) Is a Nortriptyline 30mg / Fluphenazine 1.5mg tablets true Inferred relationship Existential restriction modifier
Motipress tablets (Sanofi-Synthelabo Ltd) Is a Nortriptyline 30mg / Fluphenazine 1.5mg tablets false Inferred relationship Existential restriction modifier
Motipress tablets (Sanofi-Synthelabo Ltd) Has active ingredient Nortriptyline hydrochloride false Inferred relationship Existential restriction modifier
Motipress tablets (Sanofi-Synthelabo Ltd) Has active ingredient Fluphenazine hydrochloride false Inferred relationship Existential restriction modifier
Motipress tablets (Sanofi-Synthelabo Ltd) Has active ingredient Nortriptyline false Inferred relationship Existential restriction modifier
Motipress tablets (Sanofi-Synthelabo Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Motipress tablets (Sanofi-Synthelabo Ltd) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Motipress tablets (Sanofi-Synthelabo Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Motipress tablets (Sanofi-Synthelabo Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Motipress tablets (Sanofi-Synthelabo Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Motipress tablets (Sanofi-Synthelabo Ltd) Is a Motipress true Inferred relationship Existential restriction modifier
Motipress tablets (Sanofi-Synthelabo Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Nortriptyline true Inferred relationship Existential restriction modifier
Motipress tablets (Sanofi-Synthelabo Ltd) Has specific active ingredient Nortriptyline hydrochloride true Inferred relationship Existential restriction modifier
Motipress tablets (Sanofi-Synthelabo Ltd) Has specific active ingredient Fluphenazine hydrochloride true Inferred relationship Existential restriction modifier
Motipress tablets (Sanofi-Synthelabo Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Motipress tablets (Sanofi-Synthelabo Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Motipress tablets (Sanofi-Synthelabo Ltd) Has basis of strength substance Nortriptyline true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Motipress tablets (Sanofi-Synthelabo Ltd) 28 tablet Is pack of False Motipress tablets (Sanofi-Synthelabo Ltd) Inferred relationship Existential restriction modifier
Motipress tablets (Sanofi-Synthelabo Ltd) 28 tablet Has AMP True Motipress tablets (Sanofi-Synthelabo Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start